Skip to main content
. 2022 May 20;41(2):396–402. doi: 10.5534/wjmh.210244

Table 1. Selected variables on patient demographics pre- and post-PAE at 6 and 12-months.

Variable Patient 1 Patient 2 Patient 3 Patient 4 Patient 5 Patient 6
Age (y) 44 52 66 48 49 55
Duration of BPH (y) 2 4 5 3 4 3
Preoperative IPSS score 18 16 14 16 17 18
Preoperative IIEF-5 score 21 22 21 22 21 21
Preoperative Qmax (mL/s) 8.2 7.6 6.9 8.1 7.6 8.0
Prostate volume on CTA (cm3) 75 80 100 82 80 68
Duration of PAE procedure (min) 60 45 65 55 65 55
Postoperative IPSS score at 6 months 16 14 10 14 14 12
Postoperative IIEF-5 score at 6 months 19 18 18 19 18 19
Postoperative Qmax (mL/s) at 6 months 14.5 12.3 8.8 11.8 13.5 13.8
Postoperative IPSS score at 12 months 14 12 10 12 14 10
Postoperative IIEF-5 score at 12 months 19 18 18 18 17 18
Postoperative Qmax (mL/s) at 12 months 14 12 8 10 12 12
Treatment received for PGN HBOT Conservative HBOT HBOT Conservative HBOT
Time to resolution of glans penis colour (mo) 3 6 3 4 6 4

PAE: prostatic artery embolization, BPH: benign prostatic hyperplasia, IPSS: International Prostate Symptom Severity, IIEF: International Index of Erectile Function, CTA: computed tomography angiogram, PGN: penile glans necrosis, HBOT: hyperbaric oxygen therapy.